Previous Close | 9.42 |
Open | 9.43 |
Bid | 9.70 x 400 |
Ask | 9.75 x 100 |
Day's Range | 9.25 - 9.81 |
52 Week Range | 4.97 - 16.75 |
Volume | |
Avg. Volume | 6,175,119 |
Market Cap | 2.315B |
Beta (5Y Monthly) | 0.85 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
On May 14, 2024, Blake Borgeson, Director at Recursion Pharmaceuticals Inc (NASDAQ:RXRX), executed a sale of 20,054 shares of the company.
Recursion Pharmaceuticals ( NASDAQ:RXRX ) First Quarter 2024 Results Key Financial Results Revenue: US$13.8m (up 14...
Insight into Recursion Pharmaceuticals' Financial Health and Strategic Advances